Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Major Science and Technology Projects of China (2012ZX10002001, 2018ZX10721202)
- National Science and Technology Major Project (2012ZX10002001, 2018ZX10721202)
This publication has 21 references indexed in Scilit:
- Comparison of Immunogenicity and Safety of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-Infected Adults: A Randomized, Controlled TrialPLOS ONE, 2013
- Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?International Journal of STD & AIDS, 2013
- Hepatitis B and the Need for a Booster DoseClinical Infectious Diseases, 2011
- Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patientsVaccine, 2009
- Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected personsInternational Journal of STD & AIDS, 2008
- Undetectable Plasma HIV RNA Load Predicts Success after Hepatitis B Vaccination in HIV-Infected PersonsClinical Infectious Diseases, 2005
- Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double doseVaccine, 2005
- Hepatitis A and B Vaccination Practices for Ambulatory Patients Infected with HIVClinical Infectious Diseases, 2004
- Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohortJournal of Adolescent Health, 2001
- Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1991